Patient adherence and medical treatment outcomes A meta-analysis

Medical Care

Volumn 40, Issue 9, 2002, Pages 794-811

  Robin Dimatteo, M ^a   Giordani, Patrick J ^a   Lepper, Heidi S ^b   Croghan, Thomas W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DRAKE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Health outcomes; Meta analysis; Patient adherence compliance

Indexed keywords

ARTICLE; CLINICAL TRIAL; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RISK FACTOR; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; RISK FACTORS;

EID: 0036719562     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200209000-00009     Document Type: Article

References (111)

1. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA 1994;271:79-83.
2. DiMatteo MR, DiNicola DD, Achieving Patient Compliance. Elmsford, NY: Pergamon; 1982.
3. Shumaker SA, Schron EB, Ockene JK, et al, eds. The Handbook of Health Behavior Change, 2nd ed. New York, NY: Springer; 1998.
4. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol 1982;50:950-971.
5. Brownell KD, Cohen LR. Adherence to dietary regimens: 1. An overview of research. Behav Med 1995;20:149-154.
6. Wilfley D, Brownell KD. Physical activity and diet in weight loss. In: Dishman RK, ed. Advances in exercise adherence. Champaign, IL: Human Kinetics 1994:361-393.
7. Norman P, Abraham C, Conner M, eds. Understanding and changing health behaviour: From health beliefs to self-regulation. Amsterdam: Harwood; 2000.
8. Joshi N, Milfred D. The use and misuse of new antibiotics: A perspective. Arch Intern Med 1995;155:569-577.
9. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
10. DiMatteo MR, Hays RD, Gritz ER, et al. Patient adherence to cancer control regimens: Scale development and initial validation. Psychol Assessment 1993;5:102-112.
11. McCaul KD, Glasgow RE, Schafer LC. Diabetes regimen behaviors: Predicting adherence. Med Care 1987;25:868-881.
12. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: A meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107.
13. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985;20:29-37.
14. Lambert BL, Street RL, Cegala DJ, et al. Provider-patient communication, patient-centered care, and the mangle of practice. Health Commun 1997;9:27-43.
15. Korsch BM, Gozzi EK, Francis V. Gaps in doctor-patient communication. I: Doctor-patient interaction and patient satisfaction. Pediatrics 1968;42:855-871.
16. Davis MS. Variations in patients' compliance with doctors' advice: An empirical analysis of patterns of communication. Am J Public Health 1968;58:274-288.
17. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-1161.
18. Rosenthal R, DiMatteo MR. Meta-analysis: Recent developments in quantitative methods for literature reviews. Ann Rev Psychol 2001;52:59-82.
19. Trostle JA. Patient compliance as an ideology. In: Gochman DS, ed. Handbook of health behavior research II: Provider determinants. New York, NY: Plenum; 1997:109-122.
20. Rosenthal R, Rosnow RL. Essentials of Behavioral Research. 2nd ed. New York, NY: McGraw-Hill; 1991.
21. Ettinger WH, Burns R, Messier SP, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: The Fitness Arthritis and Seniors Trial (FAST). JAMA 1997;277:25-31.
22. De Klerk E, Der Linden SJ. Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol 1996;35:60-65.
23. Dekker AW, Rozenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: A comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987;160:7-12.
24. Fisher B, Brown A, Wolmark N, et al. Evaluation of the worth of Corynebacteriurn parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight year results from the National Surgical Adjuvant Breast and Bowel Project B-10. Cancer 1990;66:220-227.
25. Foucar K, Duncan MH, Stidley CA, et al. Survival of children and adolescents with acute lymphoid leukemia. Cancer 1991;67:2125-2130.
26. Pizzo PA, Robichaud KJ, Edwards BK, et al. Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial. J Pediatrics 1983;102:125-133.
27. Richardson JL, Shelton DR, Krailo M, et al. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990;8:356-364.
28. Glasgow RE, Toobert DJ, Riddle M, et al. Diabetes-specific social learning variables and self-care behaviors among persons with type II diabetes. Health Psychol 1989;8:285-303.
29. Hadden DR, Montgomery DAD, Skelly RJ, et al. Maturity onset diabetes mellitus: Response to intensive dietary management. BMJ 1975;3:276-278.
30. Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol 1990;9:632-646.
31. Murphy LMB, Thompson RJ, Morris MA. Adherence behavior among adolescents with type I insulin-dependent diabetes mellitus: The role of cognitive appraisal processes. J Ped Psychol 1997;22:811-825.
32. Strychar IM, Blain E, Rivad M, et al. Association between dietary adherence measures and glycemic control in outpatients with type 1 diabetes mellitus and normal serum lipid levels. J Am Dietetic Assoc 1998;98:76-79.
33. Birch EE, Stager DR. Prevalence of good visual acuity following surgery for congenital unilateral cataract. Arch Ophthal 1988;106:40-43.
34. Granstrom P. Progression of visual field defects in glaucoma. Arch Ophthalmol 1985;103:529-531.
35. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986;101:524-530.
36. Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986;102:340-345.
37. Glynn RJ, Buring JE, Manson JE, et al. Adherence to aspirin in the prevention of myocardial infarction: The Physicians' Health Study. Arch Intern Med 1994;154:2649-2657.
38. Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990;336:542-545.
39. Reis GJ, Boucher TM, Sipperly ME, et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989;2:177-181.
40. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996;101:270-276.
41. Romm FJ, Hulka BS, Mayo F. Correlates of outcomes in patients with congestive heart failure. Med Care 1976;14:765-776.
42. Thornton MA, Gruentzig AR, Hollman J, et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 1984;69:721-727.
43. Warner JG, Brubaker PH, Zhu Y, et al. Longterm (5 year) changes in HDL cholesterol in cardiac rehabilitation patients: Do sex differences exist? Circulation 1995;92:773-777.
44. Coronary Drug Project. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980;303:1038-1041.
45. Hoeg JM, Maher MB, Bou E, et al. Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin. Circulation 1984;70:1004 -1011.
46. Jacobson TA, Chin MM, Curry CL, et al. Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia. Arch Intern Med 1995;155:1900-1906.
47. Lambert M, Lupien P, Gagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin. Pediatrics 1996 97:619-628.
48. McCrindle BW, O'Neill MB, Cullen-Dean G, et al. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, controlled trial. J Pediatrics 1997;130:266-273.
49. Malloy MJ, Kane JP, Rowe JS. Familial hypercholesterolemia in children: Treatment with p-Aminosalicydic acid. Pediatrics 1978;61:365-372.
50. Schectman G, Hiatt J, Hartz A. Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium, and lovastatin) for treating hypercholesterolemia in veterans. Am J Cardiol 1993;71:759-765.
51. Briggs WA, Lowenthal DT, Cirksena WJ, et al. Propranolol in hypertensive dialysis patients: efficacy and compliance. Clin Pharmacol Ther 1975;18:606-612.
52. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-764.
53. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
54. Morrell RW, Park DC, Kidder DP, et al. Adherence to antihypertensive medications across the life span. Gerontologist 1997;37:609-619.
55. Podell RN, Kent D, Keller K. Patient psychological defense and physician response in the long-term treatment of hypertension. J Fam Prac 1976;3:145-149.
56. Widmer RB, Cadoret RJ, Troughton E. Compliance characteristics of 291 hypertensive patients from a rural Midwest area. J Fam Prac 1983;17:619-625.
57. Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: A randomised, placebo controlled trial. Gut 1997;40:485-491.
58. Colaco J, Egan-Mitchell B, Stevens FM, et al. Compliance with gluten free diet in coeliac disease. Arch Dis Childhood 1987;62:706-708.
59. Congdon P, Mason MK, Smith S, et al. Smallbowel mucosa in asymptomatic children with celiac disease: Mucosal changes with gluten-free diets. Am J Dis Child 1981;135:118-121.
60. Mayer M, Greco L, Troncone R, et al. Compliance of adolescents with coeliac disease with a gluten free diet. Gut 1991;32:881-885.
61. Rappaport L, Landman G, Fenton T, et al. Locus of control as predictor of compliance and outcome in treatment.of encopresis. J Pediatrics 1986;109:1061-1064.
62. Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: A controlled study. J Laryngol Otol 1988;102:491-495.
63. Kulik JA, Carlino P. The effect of verbal commitment and treatment choice on medication compliance in a pediatric setting. J Behav Med 1987;10:367-376.
64. Macknin ML, Jones PK. Oral dexamethasone for treatment of persistent middle ear effusion. Pediatrics 1985;75:329-335.
65. Mattar ME, Markello MD, Yaffe SJ. Pharmaceutic factors affecting pediatric compliance. Pediatrics 1975;55:101-108.
66. Reed BD, Lutz LJ, Zazove P, et al. Compliance with acute otitis media treatment. J Fam Prac 1984;19:627-632.
67. Schwartz RH, Puglise J, Rodriguez WJ. Sulphamethoxazole prophylaxis in the otitis-prone child. Arch Dis Childhood 1982;57:590-593.
68. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 1994;49:263-266.
69. Engleman HM, Cheshire KE, Dreary IJ, et al. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnea-hypopnea syndrome. Thorax 1993;48:911-914.
70. Loube DI, Loube AA, Erman MK. Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Dietetic Assoc 1997;97:896-897.
71. Meurice J, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airwar pressure treatment in sleep apnea syndrome. Chest 1994;105:429-433.
72. Rauscher H, Formanek D, Popp W, et al. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993;103:1675-1680.
73. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995;59:340-347.
74. Hilbrands LB, Hoitsma AJ, Koene RAP. Medication compliance after renal transplantation. Transplantation 1995;60:914-920.
75. Phipps S, DeCuir-Walley S. Adherence issues in pediatric bone marrow transplantation. J Ped Psychol 1990;15:459-475.
76. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in organ transplant recipients. Transplant Proc 1989;21:833-834.
77. Sketris I, Waite N, Grobler K, et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplanation Proceedings 1994;26:2538-2541.
78. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;1993:88:505-509.
79. Dohil R, Israel DM, Hassall E. Effective 2-week therapy for Helicobacter pylori disease in children. Am J Gastroenterol 1997;92:244-247.
80. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gasteroenterol 1992;102:493-496.
81. Mayberry JC, Moneta GL, Taylor LM, et al. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surgery 1991;109:575-581.
82. Samson RH, Showalter DP. Stockings and the prevention of recurrent venous ulcers. Dermatol Surg 1996;22:373-376.
83. Wright DDI, Franks FJ, Blair SD, et al. Ox-erutins in the prevention of recurrence in chronic venous ulceration: Randomized controlled trial. Br J Surg 1991;78:1269-1270.
84. Rosenthal R. Meta-Analytic Procedures for Social Research 2nd ed. Newbury Park, CA: Sage; 1991.
85. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
86. Rosenthal R, Rosnow RL, Rubin DB. Contrasts and Effect Sizes in Behavioral Research: A Correlational Approach. New York: Cambridge University Press, 2000.
87. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychol Bull 1979;86:638-641
88. Rosenberg SJ, Hayes JR, Peterson RA. Revising the Seriousness of Illness Rating Scale: modernization and re-standardization. Int J Psychiatry Med 1987;17:85-92.
89. Hedges LV, Vevea JL. Fixed- and randomeffects models in meta-analysis. Psychol Methods 1998;3:486-504.
90. Howell DC. Statistical methods for psychology. 4th ed. Belmont, CA: Duxbury Press; 1997.
91. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997;157:1921-1929.
92. Rosenthal R. Progress in clinical psychology: Is there any? Clin Psychol: Sei Practice 1995;2:133-2150.
93. Rosenfeld RM, Vertress JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatrics 1994;124:355-367.
94. Pichichero ME. Changing the treatment paradigm for acute otitis media in children. JAMA 1998;279:1748-1750.
95. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein in the progression of coronary atherosclerosis. N Engl J Med 1998;338:86-93.
96. Donovan JL, Blake DR. Patient noncompliance: Deviance or reasoned decision-making? Soc Sei Med 1992;34:507-513.
97. Epstein L. The direct effects of compliance on health outcome. Health Psychol 1984;3:385-393.
98. Czajkowski SM, Chesney MA, Smith AW. Adherence and the placebo effect. In: Shumaker SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York, NY: Springer; 1998:515-534
99. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602.
100. Page GG, Ben-Eliyahu S. The immunesuppressive nature of pain. Semin Oncol Nurs 1997 13:10-15.
101. Hays RD, DiMatteo MR. Key issues and suggestions, sources of information, focus of measures, and nature of response options. J Compliance Health Care 1987;2:37-53.
102. DiMatteo MR, Practitioner-family-patient communication in pediatric adherence: Implications for Research and Clinical Practice. In: Drotar D, ed. Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods, and Interventions. Mahwah, NJ: Lawrence Erlbaum Associates; 2000:237-258.
103. DiMatteo MR. Patient adherence to health care regimens. In: Smelser NJ, Baltes PB, eds. International Encyclopedia of the Social and Behavioral Sciences. Oxford: Pergamon/Elsevier; 2001.
104. DiMatteo MR, Robinson JD, Heritage J, et al. Correspondence among patients' self reports, chart records, and audio/videotapes of medical visits. Health Commun 2002;15:2.
105. Brody H. The Placebo Response. New York, NY: Harper Collins; 2000.
106. DiMatteo MR. Martin LR. Health Psychology. Boston, MA: Allyn & Bacon; 2002.
107. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000;160:1818-1823.
108. loannidis JP, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-1093.
109. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Ed Q 1984;11:1-47.
110. Horwitz RL, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993;153:1863-1868.
111. Golin CE, DiMatteo MR, Leake B, et al. A disease-specific measure of diabetic patients' desire to participate in medical decision-making. Diabetes Ed 2001;27:875-886.